GB0506725D0 - Combination therapy - Google Patents

Combination therapy

Info

Publication number
GB0506725D0
GB0506725D0 GB0506725A GB0506725A GB0506725D0 GB 0506725 D0 GB0506725 D0 GB 0506725D0 GB 0506725 A GB0506725 A GB 0506725A GB 0506725 A GB0506725 A GB 0506725A GB 0506725 D0 GB0506725 D0 GB 0506725D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB0506725A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
AstraZeneca AB
Original Assignee
AstraZeneca AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by AstraZeneca AB filed Critical AstraZeneca AB
Priority to GB0506725A priority Critical patent/GB0506725D0/en
Publication of GB0506725D0 publication Critical patent/GB0506725D0/en
Priority to MX2007003506A priority patent/MX2007003506A/en
Priority to KR1020077009368A priority patent/KR20070073813A/en
Priority to JP2007532962A priority patent/JP2008514576A/en
Priority to US11/663,912 priority patent/US20080015205A1/en
Priority to BRPI0516024-3A priority patent/BRPI0516024A/en
Priority to EP05786039A priority patent/EP1796672A1/en
Priority to CA002579067A priority patent/CA2579067A1/en
Priority to PCT/GB2005/003672 priority patent/WO2006035203A1/en
Priority to AU2005288736A priority patent/AU2005288736B2/en
Priority to IL181608A priority patent/IL181608A0/en
Priority to NO20071426A priority patent/NO20071426L/en
Priority to US12/408,833 priority patent/US20090325977A1/en
Ceased legal-status Critical Current

Links

GB0506725A 2004-09-27 2005-04-01 Combination therapy Ceased GB0506725D0 (en)

Priority Applications (13)

Application Number Priority Date Filing Date Title
GB0506725A GB0506725D0 (en) 2005-04-01 2005-04-01 Combination therapy
AU2005288736A AU2005288736B2 (en) 2004-09-27 2005-09-23 Cancer combination therapy comprising AZD2171 and imatinib
EP05786039A EP1796672A1 (en) 2004-09-27 2005-09-23 Cancer combination therapy comprising azd2171 and imatinib
KR1020077009368A KR20070073813A (en) 2004-09-27 2005-09-23 Cancer combination therapy comprising azd2171 and imatinib
JP2007532962A JP2008514576A (en) 2004-09-27 2005-09-23 Cancer combination therapy comprising AZD2171 and imatinib
US11/663,912 US20080015205A1 (en) 2004-09-27 2005-09-23 Cancer Combination Therapy Comprising Azd2171 and Imatinib
BRPI0516024-3A BRPI0516024A (en) 2004-09-27 2005-09-23 use of azd 2171 or a pharmaceutically acceptable salt thereof and imatinib, pharmaceutical composition, kit, and method for producing an antiangiogenic effect and / or reducing vascular permeability in a warm-blooded animal
MX2007003506A MX2007003506A (en) 2004-09-27 2005-09-23 Cancer combination therapy comprising azd2171 and imatinib.
CA002579067A CA2579067A1 (en) 2004-09-27 2005-09-23 Cancer combination therapy comprising azd2171 and imatinib
PCT/GB2005/003672 WO2006035203A1 (en) 2004-09-27 2005-09-23 Cancer combination therapy comprising azd2171 and imatinib
IL181608A IL181608A0 (en) 2004-09-27 2007-02-27 Cancer combination therapy comprising azd2171 and imatinib
NO20071426A NO20071426L (en) 2004-09-27 2007-03-16 Cancer combination therapy including AZD2171 and Imatinib
US12/408,833 US20090325977A1 (en) 2004-09-27 2009-03-23 Cancer combination therapy comprising azd2171 and imatinib

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0506725A GB0506725D0 (en) 2005-04-01 2005-04-01 Combination therapy

Publications (1)

Publication Number Publication Date
GB0506725D0 true GB0506725D0 (en) 2005-05-11

Family

ID=34586604

Family Applications (1)

Application Number Title Priority Date Filing Date
GB0506725A Ceased GB0506725D0 (en) 2004-09-27 2005-04-01 Combination therapy

Country Status (1)

Country Link
GB (1) GB0506725D0 (en)

Similar Documents

Publication Publication Date Title
HK1205935A1 (en) Non-lithotripsic kidney-stone therapy
GB0506147D0 (en) Therapeutic agents
GB0505437D0 (en) Therapeutic agents
GB0505725D0 (en) Therapeutic agents
GB0504206D0 (en) Combination therapy
GB0518819D0 (en) Therapeutic agents
GB0518817D0 (en) Therapeutic agents
GB0509052D0 (en) Combination therapy
GB0417481D0 (en) Combination therapy
GB0516661D0 (en) Therapeutic agents
GB0514738D0 (en) Therapeutic agents
GB0428180D0 (en) Combination therapy
ZA200709627B (en) Combination therapy
GB0507003D0 (en) Therapeutic
GB0424339D0 (en) Combination therapy
GB0518720D0 (en) Therapeutic combination
GB0501655D0 (en) Therapeutic use
GB0421436D0 (en) Combination therapy
GB0421438D0 (en) Combination therapy
GB0514347D0 (en) Combination therapy
GB0500659D0 (en) Combination therapy
GB0500658D0 (en) Combination therapy
GB0513778D0 (en) Combination therapy
GB0526132D0 (en) Combination Therapy
GB0506725D0 (en) Combination therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)